BioCentury
ARTICLE | Clinical News

Millennium files IND

June 12, 2000 7:00 AM UTC

MLNM filed an IND to begin U.S. Phase II testing of its LDP-02 humanized monoclonal antibody against integrin alpha(4)beta(7) to treat ulcerative colitis. The product also is in Phase II testing in Ca...